Study title:
Fluvoxamine for Children and Adolescents With
Obsessive-Compulsive Disorder: A Randomized,
Controlled, Multicenter Trial.(Statistical Data Included)
Article from: Journal of the American Academy of Child and Adolescent Psychiatry,2001 | RIDDLE, MARK A.; REEVE, ELIZABETH A.; YARYURA-TOBIAS,JOSE A.; YANG, HWA MING; CLAGHORN, JAMES L.; GAFFNEY, GARY; GREIST,JOHN H.; HOLLAND, DONNA; McCONVILLE, BRIAN J.; PIGOTT, TERESA; WALKUP,
JOHN T.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Mental Disorders [F03]
|
Brands: Please see report, Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: FLUVOXAMINE |
ATC code: |
Document link:
Bayer Pharma_Fluvoxamine Maleate_Riddle MA_2001_publication.pdf
|
Document date: 2011-09-15
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|